China Still Hasn’t Approved Pfizer Vaccine, Misses Target Date – Bloomberg

BioNTech SE’s potent Covid-19 vaccine is widely used in the U.S. and Europe, but China has yet to approve the shot, leaving questions swirling about Beijing’s plans for an inoculation that’s heavily coveted in the rest of the world. 

Regulators on China’s mainland haven’t signed off on the shot nearly nine months after it received its first regulatory clearance in the U.K.
Shanghai Fosun Pharmaceutical Group Co. — which has an agreement with BioNTech to sell it in mainland China, Hong Kong, Macau and Taiwan — has seen its shares fall about 23% below an all-time high hit in early August. 

Sorgente articolo:
China Still Hasn’t Approved Pfizer Vaccine, Misses Target Date – Bloomberg

User ID Campaign ID Link
d9a95efa0a2845057476957a427b0499 l-99999994 Marketing Automation
d9a95efa0a2845057476957a427b0499 l-99999996 Free Trial Webinar
d9a95efa0a2845057476957a427b0499 l-99999984 Cloud Real Time
d9a95efa0a2845057476957a427b0499 l-99999993 Million Dollar Page